Heron Therapeutics (HRTX) Interest Coverage Ratio: History & Chart

Heron Therapeutics, Inc.(HRTX)

Biotechnology · Cary, NC

$0.34-0.03 (-8.81%)

Delayed quote: Oct 6, 2026, 11:30 AM EDT

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from days to weeks following just a single administration. Among its commercialized products is SUSTOL (granisetron), an extended-release injectable designed to prevent both immediate and delayed nausea and vomiting triggered by moderately emetogenic chemotherapy, or specific anthracycline and cyclophosphamide combination therapies. Additionally, Heron markets CINVANTI, an intravenous formulation of aprepitant. CINVANTI, which acts as a substance P/neurokinin-1 receptor antagonist, is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients undergoing highly or moderately emetogenic cancer chemotherapy. The company's development pipeline includes ZYNRELEF, an innovative dual-acting local anesthetic that combines bupivacaine, a local anesthetic, with a low dose of the nonsteroidal anti-inflammatory drug (NSAID) meloxicam in a single fixed-dose formulation. Also in development is HTX-019, an experimental therapy aimed at preventing postoperative nausea and vomiting (PONV). Furthermore, HTX-034 is being advanced for postoperative pain management and is currently undergoing Phase Ib/II clinical trials, notably in patients recovering from bunionectomy procedures. Originally established in 1983 as A.P. Pharma, Inc., the company adopted its current name, Heron Therapeutics, Inc., in January 2014. Its corporate headquarters are situated in San Diego, California.

Cary, NC

128 employees

www.herontx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Craig Alexander Collard

View full financials

HRTX Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

0.04x

INTEREST COVERAGE RATIO AVG TTM

1.47x

INTEREST COVERAGE RATIO AVG 3Y

-8.49x

INTEREST COVERAGE RATIO AVG 5Y

-8.49x

INTEREST COVERAGE RATIO AVG 10Y

-24.28x

INTEREST COVERAGE RATIO AVG 15Y

-45.31x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-97.41%

CURRENT VS 3Y AVG

+100.45%

CURRENT VS 5Y AVG

+100.45%

CURRENT VS 10Y AVG

+100.16%

CURRENT VS 15Y AVG

+100.08%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-5.42x

median of 428 covered companies

CURRENT VS SECTOR MEDIAN

+100.70%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Heron Therapeutics, Inc. (HRTX)	$63.79M	0.04x	1.47x	-8.49x	-8.49x
Pliant Therapeutics, Inc. (PLRX)vs ›	$63.47M	-58.65x	N/A	N/A	N/A
Alps Group Inc (ALPS)vs ›	$63.23M	-66.90x	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$63.23M	-31.98x	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$63.14M	0.34x	0.34x	1.90x	3.13x
Cingulate Inc. (CING)vs ›	$65.86M	-21.57x	N/A	N/A	N/A
Gossamer Bio, Inc. (GOSS)vs ›	$66.42M	-14.86x	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$61.14M	-3392.06x	18.65x	15.79x	19.13x
Oncolytics Biotech Inc. (ONCY)vs ›	$60.22M	N/A	N/A	N/A	N/A
Connect Biopharma Holdings Limited (CNTB)vs ›	$60.27M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Heron Therapeutics, Inc. (HRTX)

$63.79M

0.04x

1.47x

-8.49x

Pliant Therapeutics, Inc. (PLRX)vs ›

$63.47M

-58.65x

N/A

Alps Group Inc (ALPS)vs ›

$63.23M

-66.90x

N/A

Kalaris Therapeutics Inc (KLRS)vs ›

$63.23M

-31.98x

N/A

InterCure Ltd. (INCR)vs ›

$63.14M

0.34x

1.90x

3.13x

Cingulate Inc. (CING)vs ›

$65.86M

-21.57x

N/A

Gossamer Bio, Inc. (GOSS)vs ›

$66.42M

-14.86x

N/A

Adicet Bio, Inc. (ACET)vs ›

$61.14M

-3392.06x

18.65x

15.79x

19.13x

Oncolytics Biotech Inc. (ONCY)vs ›

$60.22M

N/A

Connect Biopharma Holdings Limited (CNTB)vs ›

$60.27M

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Heron Therapeutics, Inc. (HRTX)?

The interest coverage ratio for HRTX stock is 0.04x.

Is Heron Therapeutics, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 0.04x is 100% above its 3-year average of -8.49x, near the high end of its 3-year range (-44.28x–6.31x).

What is the TTM average interest coverage ratio for Heron Therapeutics, Inc. (HRTX)?

The TTM average interest coverage ratio for HRTX stock is 1.47x.

What is the 3Y average interest coverage ratio for Heron Therapeutics, Inc. (HRTX)?

The 3Y average interest coverage ratio for HRTX stock is -8.49x.

What is the 5Y average interest coverage ratio for Heron Therapeutics, Inc. (HRTX)?

The 5Y average interest coverage ratio for HRTX stock is -8.49x.

What is the 10Y average interest coverage ratio for Heron Therapeutics, Inc. (HRTX)?

The 10Y average interest coverage ratio for HRTX stock is -24.28x.

What is the 15Y average interest coverage ratio for Heron Therapeutics, Inc. (HRTX)?

The 15Y average interest coverage ratio for HRTX stock is -45.31x.

DATE	INTEREST COVERAGE RATIO
2025-12-31	0.04x
2025-09-30	-1.41x
2025-03-31	6.31x
2024-12-31	0.94x
2024-09-30	-8.92x
2024-06-30	-16.11x
2024-03-31	-8.52x
2023-12-31	-4.71x
2023-09-30	-44.28x
2022-12-31	-8.23x
2017-12-31	-38.42x
2017-09-30	-74.84x
2017-06-30	-56.53x
2017-03-31	-47.86x
2016-09-30	-61.59x
2016-06-30	-269.16x
2016-03-31	-250.47x
2015-06-30	-247.46x
2015-03-31	-96.95x
2014-12-31	-92.83x
2014-09-30	-78.64x
2014-06-30	-85.41x
2014-03-31	-80.19x
2013-12-31	-65.25x
2013-09-30	-60.59x
2013-06-30	-74.55x
2013-03-31	-63.44x
2012-12-31	-43.80x
2012-09-30	-31.05x
2012-06-30	-30.00x
2012-03-31	-78.18x
2011-12-31	-87.62x
2011-09-30	-65.95x
2011-06-30	-5.86x
2011-03-31	-1315.00x
2010-09-30	-1635.00x
2009-09-30	-1213.00x

DATE

INTEREST COVERAGE RATIO

2025-12-31

0.04x

2025-09-30

-1.41x

2025-03-31

6.31x

2024-12-31

0.94x

2024-09-30

-8.92x

2024-06-30

-16.11x

2024-03-31

-8.52x

2023-12-31

-4.71x

2023-09-30

-44.28x

2022-12-31

-8.23x

2017-12-31

-38.42x

2017-09-30

-74.84x

2017-06-30

-56.53x

2017-03-31

-47.86x

2016-09-30

-61.59x

2016-06-30

-269.16x

2016-03-31

-250.47x

2015-06-30

-247.46x

2015-03-31

-96.95x

2014-12-31

-92.83x

2014-09-30

-78.64x

2014-06-30

-85.41x

2014-03-31

-80.19x

2013-12-31

-65.25x

2013-09-30

-60.59x

2013-06-30

-74.55x

2013-03-31

-63.44x

2012-12-31

-43.80x

2012-09-30

-31.05x

2012-06-30

-30.00x

2012-03-31

-78.18x

2011-12-31

-87.62x

2011-09-30

-65.95x

2011-06-30

-5.86x

2011-03-31

-1315.00x

2010-09-30

-1635.00x

2009-09-30

-1213.00x

Interest Coverage Ratio: 0.04x

HRTX Interest Coverage Ratio

HRTX Average Interest Coverage Ratio Chart

HRTX Current vs Average Interest Coverage Ratio Chart

HRTX Interest Coverage Ratio Metrics

HRTX Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

HRTX Interest Coverage Ratio History

Related Metrics